Claris Biotherapeutics, Inc.

CIK 1809726 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Claris Biotherapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 12, 2026D/A0001809726-26-000004
Aug 7, 2026D0001809726-26-000003
Sep 22, 2025D0001809726-25-000004
Mar 7, 2025D0001809726-25-000001
Jan 8, 2024D0001809726-24-000001
Oct 24, 2023D/A0001809726-23-000001
Jul 14, 2021D/A0001809726-21-000001
Apr 27, 2020D0001809726-20-000001